Prediction of Late Distant Recurrence After 5 Years of Endocrine Treatment: A Combined Analysis of Patients From the Austrian Breast and Colorectal Cancer Study Group 8 and Arimidex, Tamoxifen Alone or in Combination Randomized Trials Using the PAM50 Risk of Recurrence Score
View/ Open
Volume
33
Pagination
916 - +
DOI
10.1200/JCO.2014.55.6894
Journal
JOURNAL OF CLINICAL ONCOLOGY
Issue
ISSN
0732-183X
Metadata
Show full item recordAuthors
Sestak, I; Cuzick, J; Dowsett, M; Lopez-Knowles, E; Filipits, M; Dubsky, P; Cowens, JW; Ferree, S; Schaper, C; Fesl, CCollections
- Centre for Cancer Prevention [1276]